Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura: A Report From the SERF-TTP Research Group and the RADAR Project
- 18 September 2007
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 50 (12) , 1138-1143
- https://doi.org/10.1016/j.jacc.2007.04.093
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Novel monoclonal antibody‐based enzyme immunoassay for determining plasma levels of ADAMTS13 activityTransfusion, 2006
- Thrombotic Microangiopathy in Transplantation and MalignancySeminars in Thrombosis and Hemostasis, 2005
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasJournal of Thrombosis and Haemostasis, 2004
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndromeBlood, 2003
- TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology.Transplantation, 2002
- Clopidogrel and thrombotic thrombocytopenic purpuraThe Lancet, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- PREDICTING IN-HOSPITAL MORTALITY OF PATIENTS WITH AIDS-RELATEDPNEUMOCYSTIS CARINII PNEUMONIA: AN EXAMPLE OF HIERARCHICALLY OPTIMAL CLASSIFICATION TREE ANALYSISStatistics in Medicine, 1997